Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Dinoprostone. Found 6 abstracts

Edelman MJ, Wang X, Hodgson L, Cheney RT, Baggstrom MQ, Thomas SP, Gajra A, Bertino E, Reckamp KL, Molina J, Schiller JH, Mitchell-Richards K, Friedman PN, Ritter J, Milne G, Hahn OM, Stinchcombe TE, Vokes EE. Phase III Randomized, placebo-controlled, double-blind trial of celecoxib in addition to standard chemotherapy for advanced non-small-cell lung cancer with cyclooxygenase-2 overexpression: CALGB 30801 (Alliance). Journal of Clinical Oncology. 2017 Jul;35(19):2184-92.   PMCID: PMC5493050
Hooper KM, Yen JH, Kong W, Rahbari KM, Kuo PC, Gamero AM, Ganea D. Prostaglandin E2 Inhibition of IL-27 Production in Murine Dendritic Cells: A Novel Mechanism That Involves IRF1. J Immunol. 2017 Feb 15;198(4):1521-30.   PMCID: PMC5296337
Badawi AF, Eldeen MB, Liu Y, Ross EA, Badr MZ. Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma. Cancer Research. 2004 Feb;64(3):1181-9.
Badawi AF, Liu Y, Eldeen MB, Morrow W, Razak ZR, Maradeo M, Badr MZ. Age-associated changes in the expression pattern of cyclooxygenase-2 and related apoptotic markers in the cancer susceptible region of rat prostate. Carcinogenesis. 2004 Sep;25(9):1681-8.
Badawi AF, Habib SL, Mohammed MA, Abadi AA, Michael MS. Influence of cigarette smoking on prostaglandin synthesis and cyclooxygenase-2 gene expression in human urinary bladder cancer. Cancer Invest. 2002 Jan;20(5-6):651-6.
Yang WL, Frucht H. Cholinergic receptor up-regulates COX-2 expression and prostaglandin E(2) production in colon cancer cells. Carcinogenesis. 2000 Oct;21(10):1789-93.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Dinoprostone

Dinoprostone Prostaglandin-Endoperoxide Synthase Isoenzymes biosynthesis genetics metabolism Female Male administration & dosage pathology en [Enzymology] Messenger RNA 363-24-6 (Dinoprostone) Neoplastic Gene Expression Regulation US Gov't Support-PHS 0 (Isoenzymes) me [Metabolism] Human EC 1-14-99-1 (Prostaglandin-Endoperoxide Synthase) Apoptosis enzymology pharmacology Rats Smoking Experimental Mammary Neoplasms 0 (Sulfonamides) 41598-07-6 (Prostaglandin D2) Cytoplasmic and Nuclear Receptors Bladder Neoplasms 0 (Fluorenes) Messenger) 0 (RNA ai [Antagonists & Inhibitors] Colon Methylnitrosourea Leucine bi [Biosynthesis] Proto-Oncogene Proteins c-bcl-2 0 (15-deoxyprostaglandin J2) Interleukins Protein Kinase C 169590-42-5 (celecoxib) Urothelium 0 (Anticarcinogenic Agents) Macrophages Cyclic AMP pa [Pathology] Celecoxib Sprague-Dawley Rats Reverse Transcriptase Polymerase Chain Reaction Prostaglandin E Receptors-EP4 Subtype EC 1-14-99-1 (cyclooxygenase 2) Inbred F344 Rats Prostate cytology HT29 Cells Cultured Cells Neoplasm RNA N-Methylscopolamine Muscarinic Agonists Aged Prostaglandin D2 physiopathology Interferon Regulatory Factor-1 Colonic Neoplasms Carbachol 0 (Cyclooxygenase Inhibitors) Cyclooxygenase Inhibitors Regulatory T-Lymphocytes Double-Blind Method Middle Age ge [Genetics] Cell Division adverse effects ci [Chemically Induced] Sulfonamides 0 (Transcription Factors) EC 1-14-99 (cyclooxygenase 2) Signal Transduction Enzymologic Gene Expression Regulation 684-93-5 (Methylnitrosourea) ad [Administration & Dosage] Down-Regulation US Gov't Support-Non-PHS Case-Control Studies Reference Values Drug Synergism 0 (Bax protein) Pemetrexed pd [Pharmacology] EC 2-7-1-37 (Protein Kinase C) 61-90-5 (Leucine) Cyclooxygenase 2 Inhibitors 0 (Proto-Oncogene Proteins c-bcl-2) de [Drug Effects] immunology Disease Susceptibility pc [Prevention & Control] Antineoplastic Combined Chemotherapy Protocols Muscarinic Receptors Proto-Oncogene Proteins Up-Regulation Polymerase Chain Reaction Lung Neoplasms Cell Cycle aa [Analogs & Derivatives] Interleukin-10 Dendritic Cells Spleen Carboplatin Biological Markers Anticarcinogenic Agents Small Cell Carcinoma urine Cytoplasmic and Nuclear) 0 (Receptors 0 (Carcinogens) Middle Aged Cyclooxygenase 2 0 (Biological Markers) ag [Agonists] physiology Fluorenes Drug Dose-Response Relationship Muscarinic Antagonists EC 2-7-1 (protein kinase C alpha) drug therapy 0 (Proto-Oncogene Proteins) Neoplasm Staging Survival Rate ph [Physiology] therapeutic use Transcription Factors Disease-Free Survival Tissue Culture Mice Aging Carcinogens 35661-60-0 (N-(fluorenyl-9-methoxycarbonyl)leucine)
Last updated on Friday, August 07, 2020